Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,002
  • Shares Outstanding, K 85,997
  • Annual Sales, $ 36,120 K
  • Annual Income, $ -232,490 K
  • EBIT $ -109 M
  • EBITDA $ -18 M
  • 60-Month Beta 2.37
  • Price/Sales 0.70
  • Price/Cash Flow N/A
  • Price/Book 0.32
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.28
  • Most Recent Earnings $-0.24 on 08/07/24
  • Next Earnings Date 11/13/24 [AMC]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 279.26% ( -84.14%)
  • Historical Volatility 76.92%
  • IV Percentile 95%
  • IV Rank 50.42%
  • IV High 529.59% on 06/28/24
  • IV Low 24.63% on 09/19/24
  • Put/Call Vol Ratio 0.30
  • Today's Volume 96
  • Volume Avg (30-Day) 219
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 42,091
  • Open Int (30-Day) 40,437

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.48
  • Growth Rate Est. (year over year) +67,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2626 +6.28%
on 10/31/24
0.4326 -35.48%
on 10/09/24
-0.1417 (-33.67%)
since 10/08/24
3-Month
0.2626 +6.28%
on 10/31/24
0.6182 -54.85%
on 08/19/24
-0.1235 (-30.68%)
since 08/08/24
52-Week
0.2626 +6.28%
on 10/31/24
2.2700 -87.70%
on 12/28/23
-1.0809 (-79.48%)
since 11/08/23

Most Recent Stories

More News
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024

BNGO : 0.2791 (-5.26%)
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

BNGO : 0.2791 (-5.26%)
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

BNGO : 0.2791 (-5.26%)
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

BNGO : 0.2791 (-5.26%)
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma

BNGO : 0.2791 (-5.26%)
Bionano Announces Preliminary 3Q 2024 Revenues and Cash

BNGO : 0.2791 (-5.26%)
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024

BNGO : 0.2791 (-5.26%)
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2024.

BNGO : 0.2791 (-5.26%)
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript

BNGO earnings call for the period ending March 31, 2024.

BNGO : 0.2791 (-5.26%)
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript

BNGO earnings call for the period ending December 31, 2023.

BNGO : 0.2791 (-5.26%)

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 0.3327
2nd Resistance Point 0.3164
1st Resistance Point 0.2977
Last Price 0.2791
1st Support Level 0.2627
2nd Support Level 0.2464
3rd Support Level 0.2277

See More

52-Week High 2.2700
Fibonacci 61.8% 1.5032
Fibonacci 50% 1.2663
Fibonacci 38.2% 1.0294
Last Price 0.2791
52-Week Low 0.2626

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar